Letrozole
Metformin
Shanghai 10th People's HospitalSmall moleculePhase 4 / ApprovedActive
BBB
75/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 61/ 100
- Competitive Position
- 95/ 100
Competitive context
5 Active assets in the Metformin cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Metformin RenJi Hospital | Phase 4 | BBB |
UMBELLATINE Tianjin Anding Hospital | Phase 4 | BB |
Chiglitazar Shengjing Hospital | Phase 2/3 | B |
INSULIN SUSP ISOPHANE RECOMBINANT HUMAN University Hospital, Strasbourg, France | Phase 2 | CCC |
Semaglutide RenJi Hospital | N/A | D |
Liraglutide RenJi Hospital | N/A | D |
Same molecule, other indications
Letrozole is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →